Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 17.05.2022
Schloss Wachenheim AG
First Berlin Equity Research hat ein Research Update zu Schloss Wachenheim
AG (ISIN: DE0007229007) veröffentlicht. Analyst Simon Scholes bestätigt
seine BUY-Empfehlung und senkt das Kursziel von EUR 27,00 auf EUR 25,00.
Zusammenfassung:
In Q3 21/22 blieben Umsatz und Absatz mit €70,9 Mio. (FBe: €74,6 Mio.; Q3
20/21: €71, [ … ]
Tue, 17.05.2022
EPTI AB
Upcoming Investor Event:
EPTI to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, EPTI AB will also present its business model and current business
development.
Presentation slot:
EPTI AB (ISIN: SE0013774668)
05.20 am EST (New York, Toronto time)
11.20 a [ … ]
Tue, 17.05.2022
All for One Group SE
Expansion track continues unabated in Q2, sales guidance raised moderately
In the first half of 2021/22, the All for One Group (ISIN DE0005110001,
Prime Standard, A1OS GY) was able to expand revenue to €230.4 million
(+24%). The organic growth rate of 10% shown in Q1 (calendar Q4) was
confirmed in Q2 despite an increasingly challenging env [ … ]
Mon, 16.05.2022
Defence Therapeutics Inc.
Upcoming Investor Event:
Defense Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Defense Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Defense Therapeutics Inc. (ISIN: CA24 [ … ]
Mon, 16.05.2022
Energiekontor AG
First Berlin Equity Research hat ein Research Update zu Energiekontor AG
(ISIN: DE0005313506) veröffentlicht. Analyst Dr. Karsten von Blumenthal
stuft die Aktie auf BUY herauf aber senkt das Kursziel von EUR 105,00 auf
EUR 103,00.
Zusammenfassung:
Energiekontor (EKT) hat ihren Q1-Zwischenbericht veröffentlicht, der einen
qualitativen & [ … ]
Sat, 14.05.2022
Cardiol Therapeutics Inc.
Upcoming Investor Event:
Cardiol Therapeutics Inc. to present at digital International Investment
Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Cardiol Therapeutics Inc. will also present its business model and
current business development.
Presentation slot:
Cardiol Therapeutics Inc. (ISIN: CA14 [ … ]
Fri, 13.05.2022
Aspermont Ltd.
Upcoming Investor Event:
Aspermont to present at digital International Investment Forum (IIF)
On May 19, the IIF International Investment Forum will take place. At this
forum, Aspermont Ltd. will also present its business model and current
business development.
Presentation slot:
Aspermont Ltd. (ISIN: AU000000ASP3)
04.00 am EST (New York, To [ … ]
Thu, 12.05.2022
Knaus Tabbert AG
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG
(ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 87,00.
Zusammenfassung:
Die Dreimonatsergebnisse lagen nahe an unseren Schätzungen und
erwartungsgemäß unter den Vorja [ … ]
Thu, 12.05.2022
PNE AG
First Berlin Equity Research hat ein Research Update zu PNE AG (ISIN:
DE000A0JBPG2) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt
seine REDUCE-Empfehlung und erhöht das Kursziel von EUR 11,50 auf EUR
12,00.
Zusammenfassung:
PNE hat dank der herausragenden Leistung ihres Stromerzeugung-Segments
hervorragende Q1-Zahle [ … ]
Thu, 12.05.2022
CENIT AG
Q1 2022: Revenues slightly up, earnings slightly down year-on-year;
inorganic effects not yet included; we confirm our forecasts; price target
changes due to higher WACC; BUY rating confirmed
The seasonal sales trend of CENIT AG is usually characterised by lower
sales revenues in the first quarter, while the fourth quarter makes the
largest cont [ … ]